ClinicalTrials.Veeva

Menu

Chlamidia Antibodies Test for Tubal Factor Screening

I

Instituto Valenciano de Infertilidad, IVI VALENCIA

Status

Completed

Conditions

Sterility

Treatments

Other: CAT test
Other: Histerosalpingography

Study type

Interventional

Funder types

Other

Identifiers

NCT01406964
VLC-JD-0904-025

Details and patient eligibility

About

The aim of this study is to evaluate the usefulness of a Chlamydia Antibody Test for screening of tubal factor in patients who undergo artificial insemination.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 38 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age < 38 years
  • FSH < 12.
  • Treatment intrauterine insemination

Exclusion criteria

  • Insulin dependent diabetes
  • Thyroid disease
  • Severe male factor
  • Policystic ovarian syndrome
  • Previous abdominal or uterine surgery
  • Prevous abdominal or genital infections
  • Uterine myomas
  • Hidrosalpinx
  • Uterine congenital abnormalities

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Arm A
Experimental group
Description:
Arm A performs a CAT test to study tubal factor causes
Treatment:
Other: CAT test
Arm B
Experimental group
Description:
In Arm B a histerosalpingography is performed.
Treatment:
Other: Histerosalpingography

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems